US FDA approves Vera's kidney disease drug
07/07/2026 17:39
US FDA approves Vera's kidney disease drug July 7 (Reuters) - The U.S. Food and Drug Administration has approved Vera Therapeutics' VERA.O drug to treat patients with a potentially life-threatening kidney disease, the regulator said on Tuesday.
(Reporting by Siddhi Mahatole and Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
Recent news on Travere Therapeutics
See all newsBrief: Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Travere Therapeutics - Receives USPTO Notice Of Allowance For Filspari Patent In FSGS
Brief: Travere Therapeutics Announces Planned Chief Executive Officer Transition
Brief: Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule